| 31 |
Posttherapy technetium-99m pentavalent dimercaptosuccinic acid brain single-photon emission computed tomography/computed tomography: diagnostic and prognostic values in patients with glioma |
2022 |
| 32 |
Rare sites of metastases in patients with differentiated thyroid carcinoma and added value of SPECT/CT over planar whole body radioactive iodine scan |
2022 |
| 33 |
Volumetric parameters of the primary tumor and whole-body tumor burden derived from baseline 18F-FDG PET/CT can predict overall survival in non-small cell … |
2022 |
| 34 |
Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma |
2021 |
| 35 |
Brown adipose tissue (BAT) activation at 18F-FDG PET/CT: correlation with clinicopathological characteristics in breast cancer |
2021 |
| 36 |
CHALLENGES OF PATIENTS WITH A RARE COMBINATION OF MULTIPLE PRIMARY MALIGNANCIES: A SINGLE-CENTER EXPERIENCE AND A CASE SERIES STUDY |
2021 |
| 37 |
Concurrent use of nivolumab and radiotherapy for patients with metastatic non‑small cell lung cancer and renal cell carcinoma with oligometastatic disease progression on nivolumab |
2021 |
| 38 |
Does bevacizumab carry a hope for metastatic triple-negative breast cancer in the era of immunotherapy? |
2021 |
| 39 |
Role of hepatobiliary scintigraphy with different semi-quantitative parameters along with histopathological scoring in differentiating biliary atresia from neonatal hepatitis |
2021 |
| 40 |
Ablation outcomes of low versus high doses of radioiodine (131 I) in patients with differentiated thyroid carcinoma following thyroidectomy |
2020 |